Dong-A ST introduces a new antiviral with Japanese TAKARA BIO INC

Published: 2018-08-27 16:33:00
Updated: 2018-08-27 17:54:53

Dong-A ST(CEO/President Dae-Shik Eom) announced on the 23rd that they signed an agreement to introduce a new antiviral with a Japanese biotechnology company TAKARA BIO INC(CEO Nakao Koichi), which develops gene and cell therapies, in Tokyo, Japan on the 22nd.

Under the agreement, Dong-A ST will ...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.